Revised SPC: Velcade (bortezomib) 3.5mg powder for solution for injection

Publisher:
Glenmark Pharmaceuticals Europe Ltd
Publication date:
07 August 2013

Abstract

SPC updated with new indication: use in combination with dexamethasone or with dexamethasone and thalidomide, for induction treatment of adult patients with previously untreated multiple myeloma eligible for high-dose chemotherapy with haematopoietic stem cell transplantation.